At the 61st ASH Annual Meeting & Exposition, John Mascarenhas, Mount Sinai, discusses his presentation: Present Strategies and Future Directions: Treating MDS and MPN.
Questions
1. What are the major challenges in the treatment of patients with myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs)? (0:05)
2. What have been the most important recent advances in the treatment of MDS/MPN (first line and relapsed)? (1:10)
3. What factors should be considered when selecting the most appropriate treatment for an individual? (2:38)
4. What is the best treatment strategy for patients who experience symptomatic disease progression? (3:08)
5. How do you expect the treatment landscape to evolve in the coming years? (4:00)
John Mascarenhas has no conflicts of interest to declare in relation to this video.
Filmed at the 61st ASH Annual Meeting & Exposition 2019, Orlando, FL, USA.
